Very Rare Cancer Consortium Tumor Board Meeting

January 21, 2021, 4:00pm – 6:00pm | New York Genome Center

Please join us for the Very Rare Cancer Consortium Tumor Board Meeting. This new initiative aims to bring cancer researchers across New York to the table to discuss compelling rare cancer cases presented by physicians and scientists from the New York Genome Center’s partner institutions. Click here to learn more about the Very Rare Cancer Consortium.

Thursday, January 21, 2021
4pm – 6pm


Case Conference 

This will be a VIRTUAL meeting via Zoom.
Please note registration is required.



Jing Chen, MD
Pediatric Hematology-Oncology
Hackensack Meridian Health Hackensack University Medical Center

Relapsed AML with NUP98-KDM5A Fusion”


Mahmut Yaser Çeliker, MD
Pediatric Hematology & Medical Oncology
Maimonides Children’s Hospital

“Use of FLT3 Inhibitors in 16-Year-Old with AML


Elli Papaemmanuil, PhD
Assistant Attending,
Computational Oncology
Memorial Sloan Kettering Cancer Center

“Utility of Low-Pass Whole-Genome Sequencing for Peds Leukemia”  
(Copresented with Jesus Gutierrez-Abril, PhD)


Jesus Gutierrez-Abril, PhD
Research Fellow, Elli Papaemmanuil Laboratory
Memorial Sloan Kettering Cancer Center 


Christopher J. Forlenza, MD
Pediatric Hematology-Oncology
Memorial Sloan Kettering Cancer Center 

“Atypical Lymphomatous Relapse of T-ALL”


Alycia Foti, MD
Division of Pediatric Hematology/Oncology/Stem Cell Transplantation
Columbia Irving Medical Center  

“ALK+ Large B-Cell Lymphoma”


Any questions on this event, contact